In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

RDO brings in $11.5mm for AEterna Zentaris

Executive Summary

AEterna Zentaris Inc. (mainly develops therapies for cancer and endocrinology disorders) netted $11.5mm through the registered direct offering of 8.8mm common shares at $1.37 each (a 7% discount) to institutional investors. The company also issued five-year warrants to purchase 4.4mm common shares exercisable at the same price. Rodman & Renshaw was the placement agent.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies